UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 14, 2022
Accession Number:
Submission Type:
CIK: 0001536196
Company Name: Can-Fite BioPharma Ltd.
File Number: 333-262055